Posted inBusiness

Briefcase

AstraZeneca rejects takeover offer from Pfizer AstraZeneca on Monday rejected a $119 billion takeover offer from U.S. drugmaker Pfizer. Pfizer, which is the world’s second-biggest drugmaker by revenue, has been courting No. 8 AstraZeneca since January, arguing their businesses are complementary. On Sunday, it raised its stock-and-cash offer by 15 percent to $118.8 billion. That […]

advertisement